August 22, 2019 / 7:11 AM / 6 months ago

Denmark's Novo Nordisk files lawsuit against Mylan over patent

FILE PHOTO: The logo of Danish multinational pharmaceutical company Novo Nordisk is pictured on the facade of a production plant in Chartres, north-central France, April 21, 2016. REUTERS/Guillaume Souvant/Pool/File Photo

COPENHAGEN (Reuters) - Novo Nordisk (NOVOb.CO) said on Thursday it has filed litigation in a Delaware district court against Mylan (MYL.O) aimed at blocking its attempt to market a generic version of the Danish insulin maker’s drug Victoza.

“We can confirm that Novo Nordisk has filed a lawsuit against Mylan for patent infringement of Victoza,” the company said in an e-mail.

The news was first reported by Bloomberg.

Reporting by Andreas Mortensen; editing by Jason Neely

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below